Skip to main content

Startup spun out of SLU raises $30M in Series A funding

The preclinical-stage biopharmaceutical startup, BioIntervene, was spun out of research from by SLU professor Daniela Salvemini.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.